BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26716894)

  • 1. MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.
    Wang Z; Liu Y; Zhang Y; Shang Y; Gao Q
    Oncotarget; 2016 Jan; 7(4):4760-9. PubMed ID: 26716894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.
    Wang Z; Zhang Y; Liu Y; Wang L; Zhao L; Yang T; He C; Song Y; Gao Q
    J Immunother; 2014 Jan; 37(1):43-50. PubMed ID: 24316555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy.
    Mai HX; Mei GH; Zhao FL; Li BT; Tang YY; Zhang B; Xu XJ; Chen LJ
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S427-S432. PubMed ID: 29970701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
    Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R; Guo T
    Cancer Biother Radiopharm; 2010 Aug; 25(4):465-70. PubMed ID: 20701541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.
    Zhao X; Zhang Z; Li H; Huang J; Yang S; Xie T; Huang L; Yue D; Xu L; Wang L; Zhang W; Zhang Y
    Cancer Lett; 2015 Jul; 362(2):192-8. PubMed ID: 25843292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in metastatic brain tumor patients.
    Li W; Wang Y; Zhao L; Xu L; Zhang Y; Mai L; Gao Q
    Oncol Res Treat; 2015; 38(4):160-5. PubMed ID: 25877939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic efficacy of dendritic cells pulsed by autologous tumor cell lysate in combination with CIK cells on advanced renal cell carcinoma].
    Wang H; Feng F; Zhu M; Wang R; Wang X; Wu Y; Zhuang Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):67-71. PubMed ID: 25575061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma.
    Zhan HL; Gao X; Pu XY; Li W; Li ZJ; Zhou XF; Qiu JG
    Chin Med J (Engl); 2012 Nov; 125(21):3771-7. PubMed ID: 23106871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of sorafenib and cytokine-induced killer cells in metastatic renal cell carcinoma: a potential regimen.
    Yang Y; Lin H; Zhao L; Song Y; Gao Q
    Immunotherapy; 2017 Jun; 9(8):629-635. PubMed ID: 28653574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.
    Niu Q; Wang W; Li Y; Qin S; Wang Y; Wan G; Guan J; Zhu W
    Int Immunopharmacol; 2011 Apr; 11(4):449-56. PubMed ID: 21215350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
    Jiang N; Qiao G; Wang X; Morse MA; Gwin WR; Zhou L; Song Y; Zhao Y; Chen F; Zhou X; Huang L; Hobeika A; Yi X; Xia X; Guan Y; Song J; Ren J; Lyerly HK
    Clin Cancer Res; 2017 Sep; 23(17):5066-5073. PubMed ID: 28611200
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.
    Liu L; Zhang W; Qi X; Li H; Yu J; Wei S; Hao X; Ren X
    Clin Cancer Res; 2012 Mar; 18(6):1751-9. PubMed ID: 22275504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant dendritic cells vaccine combined with cytokine-induced-killer cell therapy after renal cell carcinoma surgery.
    Zheng K; Tan JM; Wu WZ; Qiu YM; Zhang H; Xu TZ; Sun XH; Zhuo WL; Wang D; Zhang JP
    J BUON; 2015; 20(2):505-13. PubMed ID: 26011343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
    Wu C; Jiang J; Shi L; Xu N
    Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.
    Zhao L; Li T; Song Y; Yang Y; Ma B; Zhang Y; Shang Y; Xu B; Guo J; Qin P; Han L; Fu X; Lin H; Liu L; Ren X; Wang Z; Gao Q
    Front Immunol; 2021; 12():779248. PubMed ID: 35058923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.
    Han L; Shang YM; Song YP; Gao QL
    J Immunol Res; 2016; 2016():5706814. PubMed ID: 27433478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.